Truist analyst Robyn Karnauskas recaps recently announced drug price changes by Biogen (NASDAQ: BIIB), Regeneron (NASDAQ: REGN), Vertex Pharma (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments FDA Trader Talk

Biogen (BIIB) PT Lowered to $335 at Canaccord GenuityJanuary 3, 2022 4:30 AM Biogen (BIIB) puts more active than calls after Samsung Group denies in talks to acquire December 30, 2021 11:17 AM Increasing unusual put option volume: ASTR BIIBDecember 30, 2021 9:42 AM Pre-Open Stock Movers 12/30: (NAKD) (KR) (TSCO) Higher; (BIIB) (DIDI) (MDGL) Lower (more...)December 30, 2021 9:29 AM UPDATE: Biogen (BIIB) PT Raised to $284 at Wells FargoDecember 30, 2021 8:17 AM 'Best-Case Exit Strategy': Biogen (BIIB) Stock Falls as Takeover Rumor Denied, But Analysts Bullish on Takeover ProspectDecember 30, 2021 8:07 AM Biogen (BIIB) options active after speculation in Korean press December 30, 2021 4:56 AM Increasing unusual call option volume: BIIB EIX MDLZ WPC BBD ITWDecember 30, 2021 4:34 AM